India is among top 12 biotech markets globally, and ranks third in the Asia-Pacific region, after Japan and Korea. The Indian market is expected to touch US$ 5 billion by 2010 and US$ 25 billion by 2015. In 2008-09, revenues for the biotech industry stood at US $ 2.67 billion.
The industry in 2008–09 clocked US$ 2.67 billion registering a 18 per cent growth (in value) over the previous fiscal. Growth has been mainly fuelled by rise in domestic business, exports and new product innovations. India’s main bio-clusters are located in Bangalore, Hyderabad, Pune-Mumbai and Ahmedabad-Vadodara.
Sectoral Presentation (September 2009)
Click Here to Download 
. Size:431 kb